Vikas Sinha

Mr. Sinha has served as a Non-Executive Director on the board of directors since September 2016.

Mr. Sinha has over 20 years of experience working in executive finance roles in the life sciences industry. Mr. Sinha is Chief Financial Officer and co-founder of ElevateBio, a holding company focused on building cell and gene therapy companies. He also serves as President and Chief Financial Officer of AlloVir, an ElevateBio portfolio company. In addition, Mr. Sinha serves as a member of the board of directors of Allovir and BCLS Acquisition Corp. From 2005 to 2016, he was the Chief Financial Officer of Alexion Pharmaceuticals. Prior to joining Alexion, Mr. Sinha held various positions with Bayer across the world including CFO, Bayer North America, and CFO Bayer Yakuhin, Japan. Mr. Sinha holds an MBA in business administration from the Asian Institute of Management. He is a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the US.